Skip to main content
. 2021 Mar 22;2021:6626094. doi: 10.1155/2021/6626094

Table 5.

Candidate drug targeting genes with PAH.

Gene Drug Sources Reference (PMID)
SPP1 Alteplase NCI 12009309
SPP1 Gentamicin NCI 11274264
SPP1 Tacrolimus NCI 16103732
SPP1 Calcitonin NCI 8013390
VCAM1 Cyclosporine NCI 7694584
VCAM1 Carvedilol DrugBank 17139284, 15374848, 17016423
VCAM1 Alcohol DrugBank 18165316
VCAM1 Mercaptopurine NCI 7694584
VCAM1 Dexamethasone NCI 7694584
CXCL12 Vincristine PharmGKB 27173875
CXCL12 Alemtuzumab PharmGKB 27173875
CXCL12 Prednisone PharmGKB 27173875
CXCL12 Cyclophosphamide PharmGKB 27173875
CXCL12 Chlorambucil PharmGKB 27173875
CXCL12 Rituximab PharmGKB 27173875
CXCR1 Ibuprofen TTD N/A
CXCR1 Ketoprofen DrugBank 9093816, 15974585, 11331079

Note: PAH: pulmonary arterial hypertension; NCI: National Cancer Institute; TTD: Therapeutic Target Database; N/A: not available.